Array Biopharma Inc (NASDAQ:ARRY) and Pierre Fabre today jointly announced top-line results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used …
Atara Biotherapeutics Inc (NASDAQ:ATRA) On Monday December 14, 2015 shares of Atara Biotherapeutics tanked 37% after the company reported that a phase 2 …
Cantor Fitzgerald analyst Mara Goldstein released a research report on Array Biopharma Inc (NASDAQ:ARRY) reiterating a Buy rating on the stock and providing a price target …
In a research report published this morning, Cantor analyst Mara Goldstein reiterated a Buy rating on Array Biopharma (NASDAQ:ARRY) with a $9.00 price target, as …
William Blair analyst John Sonnier reiterated an Outperform rating on Array Biopharma (NASDAQ:ARRY), following the news that the company has regained worldwide rights to binimetinib …
In a research report released Thursday, Cantor analyst Mara Goldstein maintained a Buy rating on Array BioPharma (NASDAQ:ARRY) with a $9 price target, as the …
